Another important ligand of the PKC catalytic domain is riluzole (Figure 5), commonly used in the treatment of Amyotrophic Lateral Sclerosis (ALS) [61,62]. This evidence concerns the gene PRRT2 and amyotrophic lateral sclerosis.